https://www.selleckchem.com/products/AZD5438.html
Results Six months after the treatment, 12/14 (85.7 %) and 8/12(66.6%) patients in EMDA and injection groups respectively became completely dry between two consecutive clean intermittent catheterizations, which maintained in 11/14(78.5%) of patients in EMDA group compared to 6/12 (50%) of patients in injection group, 1 year after the treatment. Conclusion Patients in both groups improved after the treatment; however improvement in EMDA group was more prominent with better sustained effects. BoNTA/EMDA is a feasible, reproducible, cost b
Like
Comment
Share
